NewLink Genetics (NLNK) Tops Q3 EPS by 20c

NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.20), $0.20 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $310 thousand.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Yum! Brands (YUM) PT Lowered to $180 at Argus